Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Psychiatry
•
General Outpatient Psychiatry
•
Neuromodulation
•
Electroconvulsive Therapy
•
Ketamine
•
Transcranial magnetic stimulation
•
Depression
When do you refer patients with difficult-to-treat depression for ECT rather than other interventional psychiatric treatments such as TMS or esketamine?
Related Questions
What criteria do you use when deciding whether to start esketamine treatment for patients with treatment resistant MDD who are concomitant CNS depressants?
How do you determine the treatment course of esketamine or IV ketamine when used for treatment-resistant major depressive disorder?
When do you consider the use of zuranolone to treat postpartum depression?
How have you gone about implementing TMS in your practice or institution?
What is your experience with transcutaneous vagal nerve stimulation for the treatment of anxiety disorders and major depressive disorder?
Is there a benefit to augmenting treatment for schizophrenia by adding aripiprazole (a partial D2 agonist) to a full D2 antagonist such as haloperidol?
What is your approach for managing persistent psychotic symptoms of a hallucinogen-induced persisting psychotic disorder?
How do you manage emotional blunting due to SSRIs/SNRIs?
How do you handle elevated blood calcium levels from lithium?
How do you explain and manage transient post-ECT symptoms like irritability, tearfulness, or panic attacks that resolve within a day?
